{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:01:15Z","timestamp":1785232875585,"version":"3.55.0"},"reference-count":10,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"DOI":"10.1111\/jdv.70646","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:31:12Z","timestamp":1785231072000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe oral lichenoid reactions associated with immune checkpoint inhibitors"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7883-0533","authenticated-orcid":false,"given":"Pauline","family":"Hirtz","sequence":"first","affiliation":[{"name":"Department of Dermatology Bordeaux University Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Christophe","family":"Fricain","sequence":"additional","affiliation":[{"name":"Department of Oral Surgery Bordeaux University Hospital  Bordeaux France"},{"name":"U1026 Tissue Bioengineering, University of Bordeaux\/Inserm, Bordeaux, France, Dental School, University of Bordeaux  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1765-461X","authenticated-orcid":false,"given":"\u00c9milie","family":"G\u00e9rard","sequence":"additional","affiliation":[{"name":"Department of Dermatology Bordeaux University Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Digue","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Bordeaux University Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Daste","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Bordeaux University Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-862X","authenticated-orcid":false,"given":"Robin","family":"Zagala","sequence":"additional","affiliation":[{"name":"Department of Dermatology Bordeaux University Hospital  Bordeaux France"},{"name":"BoRdeaux Institute of onCology (BRIC) \u2010 UMR 1312 INSERM\/Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1229","authenticated-orcid":false,"given":"Marie","family":"Beylot\u2010Barry","sequence":"additional","affiliation":[{"name":"Department of Dermatology Bordeaux University Hospital  Bordeaux France"},{"name":"BoRdeaux Institute of onCology (BRIC) \u2010 UMR 1312 INSERM\/Universit\u00e9 de Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-2900","authenticated-orcid":false,"given":"Oc\u00e9ane","family":"Ducharme","sequence":"additional","affiliation":[{"name":"Department of Dermatology Bordeaux University Hospital  Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the GEMUB Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"5","key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ajoms.2025.04.011","article-title":"Incidence of oral reactions of immune\u2010related adverse events caused by immune checkpoint inhibitors","volume":"37","author":"Kurokawa A","year":"2025","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"issue":"1","key":"e_1_2_2_3_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.36401\/JIPO-23-14","article-title":"Oral toxicities associated with immune checkpoint inhibitors: meta\u2010analyses of clinical trials","volume":"7","author":"Srivastava A","year":"2024","journal-title":"J Immunother Precis Oncol"},{"issue":"19","key":"e_1_2_2_4_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194781","article-title":"Immunotherapy\u2010related Oral adverse effects: immediate sequelae, chronicity and secondary cancer","volume":"15","author":"Elad S","year":"2023","journal-title":"Cancer"},{"key":"e_1_2_2_5_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdin.2021.12.003","article-title":"Immune checkpoint inhibitor induced lichenoid reactions: a systematic review of characteristics and treatment outcomes","volume":"7","author":"Abduelmula A","year":"2022","journal-title":"JAAD Int"},{"key":"e_1_2_2_6_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.annder.2022.11.012","article-title":"Oral mucosal toxicities induced by immune checkpoint inhibitors: clinical features and algorithm management","volume":"150","author":"Vigarios E","year":"2023","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"e_1_2_2_7_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamadermatol.2025.0025","article-title":"Characterizing chronic cutaneous immune\u2010related adverse events following immune checkpoint inhibitors","volume":"161","author":"Fletcher KA","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"10","key":"e_1_2_2_8_1","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1111\/jdv.14284","article-title":"Oral lichenoid reactions associated with anti\u2010PD\u20101\/PD\u2010L1 therapies: clinicopathological findings","volume":"31","author":"Sibaud V","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"e_1_2_2_9_1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjd.21781","article-title":"Clinical associations and classification of immune checkpoint inhibitor\u2010induced cutaneous toxicities: a multicentre study from the European academy of dermatology and venereology task force of dermatology for cancer patients","volume":"187","author":"Nikolaou VA","year":"2022","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_2_2_10_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/jdv.17855","article-title":"European recommendations for management of immune checkpoint inhibitors\u2010derived dermatologic adverse events. The EADV task force \u2018dermatology for cancer patients\u2019 position statement","volume":"36","author":"Apalla Z","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"e_1_2_2_11_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jdv.70149","article-title":"Prevention and management of cutaneous immune\u2010related adverse events: EADV task force statement","volume":"40","author":"Fattore D","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70646","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:31:13Z","timestamp":1785231073000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":10,"alternative-id":["10.1111\/jdv.70646"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70646","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"2026-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70646"}}